05.11.2012 Views

Topical tacrolimus in atopic dermatitis: Effects of ... - Helda - Helsinki.fi

Topical tacrolimus in atopic dermatitis: Effects of ... - Helda - Helsinki.fi

Topical tacrolimus in atopic dermatitis: Effects of ... - Helda - Helsinki.fi

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

probably plays a protective role aga<strong>in</strong>st allergens that are ser<strong>in</strong>e proteases (Kato et al.<br />

2003). Also, some gene polymorphisms implicated <strong>in</strong> <strong>in</strong>nate immunity, for example, a<br />

polymorphism result<strong>in</strong>g <strong>in</strong> functional impairment <strong>of</strong> the <strong>in</strong>tracellular receptor for<br />

lipopolysaccharide <strong>in</strong>volved <strong>in</strong> activation <strong>of</strong> a nuclear factor necessary for T cell<br />

activation has been associated with risk for AD (Kabesch et al. 2003).<br />

A genetic association with AD has appeared <strong>in</strong> mutations <strong>of</strong> the gene cluster<br />

encod<strong>in</strong>g the epidermal differentiation complex <strong>in</strong> chromosome 1q21 (Segre 2006). The<br />

strongest evidence <strong>of</strong> genetic barrier dysfunction predispos<strong>in</strong>g to AD has been found <strong>in</strong><br />

the FLG gene encod<strong>in</strong>g the <strong>fi</strong>laggr<strong>in</strong> prote<strong>in</strong>—the same gene <strong>in</strong> which mutations are<br />

l<strong>in</strong>ked <strong>in</strong> ichtyosis vulgaris. Null mutations lead<strong>in</strong>g to <strong>fi</strong>laggr<strong>in</strong> de<strong>fi</strong>ciency occur <strong>in</strong><br />

about 6 to 10% <strong>of</strong> the European-orig<strong>in</strong> population as a semidom<strong>in</strong>ant trait and with<br />

<strong>in</strong>complete penetrance (Smith et al. 2006, Weid<strong>in</strong>ger et al. 2007). In studies look<strong>in</strong>g at<br />

AD and <strong>fi</strong>laggr<strong>in</strong> mutations, 44% <strong>of</strong> subjects with one mutant allele and 76% with both<br />

<strong>fi</strong>laggr<strong>in</strong> alleles mutant had a diagnosis <strong>of</strong> AD (Palmer et al. 2006). FLG mutations have<br />

been present <strong>in</strong> 25% <strong>of</strong> patients with IgE-associated but only 12% <strong>of</strong> patients with non-<br />

IgE-associated AD. They have also been associated with asthma <strong>in</strong> the patients with AD<br />

but not with asthma without AD (Marenholz et al. 2006, Weid<strong>in</strong>ger et al. 2007).<br />

Furthermore, these mutations associate with AD that starts early, is more severe, and<br />

persists <strong>in</strong>to adulthood (Barker et al. 2007, Stemmler et al. 2007, Weid<strong>in</strong>ger et al. 2006).<br />

Sk<strong>in</strong> barrier function<br />

One <strong>of</strong> the most crucial functions <strong>of</strong> the sk<strong>in</strong> is to form a barrier aga<strong>in</strong>st the microbes,<br />

irritants, and allergens <strong>of</strong> the exterior world. This barrier function is impaired <strong>in</strong> AD.<br />

Peptides with a molecular mass over 500 Da do not penetrate healthy normal sk<strong>in</strong>,<br />

whereas <strong>in</strong> AD, environmental allergens <strong>of</strong> up to 20 kDa may penetrate the sk<strong>in</strong> (Bos<br />

and Me<strong>in</strong>ardi 2000). This makes the sk<strong>in</strong> susceptible to environmental factors such as<br />

detergents, irritants, allergens, microbial tox<strong>in</strong>s, and physical or psychological stress.<br />

The epidermis is formed <strong>of</strong> layers <strong>of</strong> kerat<strong>in</strong>ocytes which divide <strong>in</strong> the basal layer<br />

next to the basement membrane, <strong>in</strong>creas<strong>in</strong>g their kerat<strong>in</strong>e content and flatten<strong>in</strong>g on their<br />

way to the surface <strong>of</strong> the sk<strong>in</strong> (Segre 2006). The sk<strong>in</strong> barrier is formed <strong>in</strong> the outermost<br />

part <strong>of</strong> the epidermis called the stratum corneum by compact flat layers <strong>of</strong> kerat<strong>in</strong>ocytes<br />

called corneocytes and their surround<strong>in</strong>g hydrophobic lipid matrix (Segre 2006). Active<br />

functional <strong>fi</strong>laggr<strong>in</strong> is needed to condense the corneocytes (Palmer et al. 2006), whereas<br />

the water-reta<strong>in</strong><strong>in</strong>g properties <strong>of</strong> the hydrophobic lipid matrix are provided by structural<br />

prote<strong>in</strong>s such as the ceramides (Segre 2006).<br />

Defects <strong>of</strong> epidermal differentiation such as <strong>fi</strong>laggr<strong>in</strong> mutations weaken the<br />

epidermal barrier and predispose patients with AD to epicutaneous allergic sensitization<br />

as well as to physical, microbial, and irritant sk<strong>in</strong> damage. This barrier-damage activates<br />

kerat<strong>in</strong>ocytes to produce <strong>in</strong>flammatory cytok<strong>in</strong>es and starts the <strong>in</strong>flammatory cycle<br />

lead<strong>in</strong>g to T cell activation, IgE-production, and cl<strong>in</strong>ical AD (Vickery 2007, Segre<br />

2006).<br />

14

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!